This article is over a month old and may contain outdated advice from the authorities regarding coronary heart disease.
Stay up to date in NRK’s overview, or through FHI’s website.
In the National Institute of Public Health’s weekly report for week 13, the reproduction figure for the coronavirus is 0.86. This means that each infected person infects on average 0.86 others.
The reproduction figures show that the epidemic is in a declining phase, writes FHI.
The figure is calculated from 15 March this year. There is a sharp decline from the reproduction rate in week 12, which was 1.0.
Only Møre og Romsdal has a reproduction number (R-number) which is probably increasing. In Agder, Innlandet, Nordland, and Vestfold and Telemark, the R-number is decreasing, while it is likely to decrease in Oslo, Rogaland and Viken. In other counties, the number is uncertain.
In Agder, Innlandet and Nordland, the R-number is down to 0.4, while in Møre og Romsdal it is 1.5.
After several weeks of an increase in the number of new hospital admissions, the number has been relatively stable over the past two to three weeks. So far, 205 new admissions have been reported in week 13. This is the same number as in week 12. The week before, the number was 225. 81 per cent of the new admissions in the last week are in Oslo and Viken. The number of inpatients increased most in the age group 50–69 years.
So far, 35 new patients have been reported in the intensive care unit in week 13. In the last week, 11 deaths have been reported, compared to 8 in week 12.
The number of new admissions and deaths has been relatively stable in recent weeks.
However, the trend in the number of reported cases last week is uncertain because few get tested during the Easter week. The figures for the week we are in now say more about the real situation after the holidays.
778,906 people have been vaccinated with the first dose of the coronary vaccine in Norway, FHI’s statistics show on Thursday. 291,112 people have received a second dose.
So far, FHI has registered that 53,564 people received the first dose on Wednesday, and 3,516 people received the second dose.
There may be delays in registering vaccinations that can lead to the numbers changing over time, writes FHI.
The first coronary vaccine in Norway was launched on December 27 and was produced by Pfizer and Biontech. On 15 January, the first dose of the Moderna vaccine was given, and on 7 February, the AstraZeneca vaccine was used by healthcare professionals. AstraZeneca has now been suspended, following reports of possible serious side effects.
Get the latest news delivered to your inbox
Follow us on social media networks